可调压腰大池腹腔分流手术治疗特发性颅内压增高的临床效果

Abstract
Figure/Table
References (23)
Related Citation (5)

Download: PDF (1036 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of adjustable lumboperitoneal shunt in the treatment of idiopathic intracranial hypertension (IIH). Methods The clinical data of 37 patients with visual impairment caused by IIH admitted to the Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University from January 2010 to January 2016 were retrospectively analyzed. All patients underwent adjustable lumboperitoneal shunt. Intracranial pressure, improvement of clinical symptoms before and after operation and postoperative complications were observed. Results In 37 patients, intracranial pressure decreased to below 250 mmH2O after operation. In a total of 71 sides of affected eye, the visual acuity improved on 41 eyes, including 23 eyes in the group with visual acuity ≥0.1 and 18 eyes in the group visual acuity ＜0.1. Among the 30 patients with papilledema, 24 had improved after operation. There was a significant improvement in 19 cases of the 22 patients with headache. Among the 37 patients, 2 cases had shunt obstruction and no infection occurred in all patients. Conclusion It is safe, effective and has a good short-term effect for adjustable lumboperitoneal shunt in the treatment of IIH-induced headache and papilledema, as well as the improvement of visual acuity loss and/or visual field defects. For patients with significant visual acuity loss, active treatment should be performed as soon as possible when visual loss is ≥0.1.

Key words： Idiopathic intracranial hypertension Visual acuity Visual field Papilledema Lumboperitoneal shunt

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DONG Hao LI Yong XU Yong ZHAO Jingwu SONG Guidong KANG Jun▲

Cite this article:

DONG Hao LI Yong XU Yong ZHAO Jingwu SONG Guidong KANG Jun▲. Clinical effect of adjustable lumboperitoneal shunt in the treatment of idiopathic intracranial hypertension[J]. 中国医药导报, 2020, 17(20): 93-96,110.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2020/V17/I20/93

[1] Lueck CJ，Mcilwaine GG. Idiopathic Intracranial Hypertension [J]. Pract Neurol，2002，2（5）：262.
[2] Baykan B，Ekizo■lu E，Altιokka Uzun G. An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri [J]. Agri，2015，27（2）：63-72.
[3] Celebisoy N，Gök?觭ay F，Sirin H，et al. Treatment of idiopathic intracranial hypertension：topiramatevs acetazolamide，an open-label study [J]. Acta Neurol Scand，2007，116（5）：322-327.
[4] 杨丽然.世界医学会《赫尔辛基宣言》——涉及人类受试者的医学研究的伦理原则(2008年10月修订)[J].医学与哲学，2009，30（9）：74-75.
[5] Friedman DI，Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension [J]. Neurology，2002，59（10）：1492-1495.
[6] 严广斌.NRS疼痛数字评价量表numerical rating scale [J].中华关节外科杂志：电子版，2014（3）：410.
[7] McGraw P，Winn B，Whitaker D，et al. Reliability of the Snellen chart [J]. BMJ, 1995, 310：1481-1482.
[8] Frisén L. Swelling of the optic nerve head：a staging sch-eme [J]. J Neurol Neurosurg Psychiatry，1982，45（1）：13-18.
[9] Sinclair AJ，Kuruvath S，Sen D，et al. Iscerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review [J]. Cephalalgia，2011，31（16）：1627-1633.
[10] Manfield JH，Yu KK，Efthimiou E，et al. Bariatric Surgery or Non-surgical Weight Loss for Idiopathic Intracranial Hypertension? A Systematic Review and Comparison of Meta-analyses [J]. Obes Surg，2017，27（2）：513-521.
[11] Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension [J]. Expert Rev Neurother，2015，15（8）：851-856.
[12] Lai LT，Danesh-Meyer HV，Kaye AH. Visual outcomes and headache following interventions for idiopathic intracranial hypertension [J]. J Clin Neurosci，2014，21（10）：1670-1678.
[13] Boyer EW. Idiopathic intracranial hypertension [J]. JAAPA，2019，32（5）：30-35.
[14] Fraser C，Plant GT. The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension [J]. Curr Opin Neurol，2011，24（1）：12-17.
[15] Acheson JF. Idiopathic intracranial hypertension and visual function [J]. Br Med Bull，2006，79/80：233-244.
[16] Matloob SA，Toma AK，Thorne L，et al. Surgically managed idiopathic intracranial hypertension in adults： a single centre experience [J]. Acta Neurochir （Wien），2015，157（12）：2099-2103.
[17] 解虎涛，程宏伟，李长元，等.腰大池-腹腔分流术与脑室-腹腔分流术治疗交通性脑积水疗效的系统评价[J].国际神经病学神经外科学杂志，2016，43（5）：385-390.
[18] Sugerman HJ. Lumboperitoneal shunting for pseudotumor cerebri [J]. Neurology，1998，50（3）：835-836.
[19] 王卫，张家亮，刘浩成，等.腹腔镜技术在神外分流手术中的应用体会[J].腹腔镜外科杂志，2018，23（7）：551-553.
[20] Hamdan AR，Tayel AM，El K，et al. “Benign intracranial hypertension” is a misleading name for a more serious disease：analysis of the visual outcome in cases with idiopathic intracranial hypertension [J]. Egypt J Neurosurg，2019，34：38.
[21] Yri HM，Jesen RH. Idiopathic intracranial hypertension：clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study [J]. Cephalalgia，2015， 35（7）：553-562.
[22] Satti SR. Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory IIH [J]. AJNR Am J Neuroradiol，2015，36（10）：1899-1904.
[23] Strachan R，Rodrigues D，Prakash S. Lumbo-peritoneal shunting for idiopathic intracranial hypertension： what is the optimum catheter length and placement to avoid low-pressure headaches? [J]. Cerebrospinal Fluid Research，2006，3（suppl 1）：S27.